These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23409920)

  • 1. Development of the S3Pvac vaccine against murine Taenia crassiceps cysticercosis: a historical review.
    Sciutto E; Fragoso G; Hernández M; Rosas G; Martínez JJ; Fleury A; Cervantes J; Aluja A; Larralde C
    J Parasitol; 2013 Aug; 99(4):693-702. PubMed ID: 23409920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of the S3Pvac vaccine against porcine Taenia solium cysticercosis: a historical review.
    Sciutto E; Fragoso G; Hernández M; Rosas G; Martínez JJ; Fleury A; Cervantes J; Aluja A; Larralde C
    J Parasitol; 2013 Aug; 99(4):686-92. PubMed ID: 23445359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic papaya: a useful platform for oral vaccines.
    Fragoso G; Hernández M; Cervantes-Torres J; Ramírez-Aquino R; Chapula H; Villalobos N; Segura-Velázquez R; Figueroa A; Flores I; Jiménez H; Adalid L; Rosas G; Galvez L; Pezzat E; Monreal-Escalante E; Rosales-Mendoza S; Vazquez LG; Sciutto E
    Planta; 2017 May; 245(5):1037-1048. PubMed ID: 28194565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two epitopes shared by Taenia crassiceps and Taenia solium confer protection against murine T. crassiceps cysticercosis along with a prominent T1 response.
    Toledo A; Fragoso G; Rosas G; Hernández M; Gevorkian G; López-Casillas F; Hernández B; Acero G; Huerta M; Larralde C; Sciutto E
    Infect Immun; 2001 Mar; 69(3):1766-73. PubMed ID: 11179354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization against Taenia crassiceps cysticercosis: identification of the most promising antigens in the induction of protective immunity.
    Valdez F; Hernández M; Govezensky T; Fragoso G; Sciutto E
    J Parasitol; 1994 Dec; 80(6):931-6. PubMed ID: 7799166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of the synthetic tri-peptide vaccine (S3Pvac) against porcine Taenia solium cysticercosis in search of a more effective, inexpensive and manageable vaccine.
    Sciutto E; Rosas G; Hernández M; Morales J; Cruz-Revilla C; Toledo A; Manoutcharian K; Gevorkian G; Blancas A; Acero G; Hernández B; Cervantes J; Bobes RJ; Goldbaum FA; Huerta M; Diaz-Orea A; Fleury A; de Aluja AS; Cabrera-Ponce JL; Herrera-Estrella L; Fragoso G; Larralde C
    Vaccine; 2007 Feb; 25(8):1368-78. PubMed ID: 17188784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fact or hypothesis: Taenia crassiceps as a model for Taenia solium, and the S3Pvac vaccine.
    Lightowlers MW
    Parasite Immunol; 2010; 32(11-12):701-9. PubMed ID: 21039610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards a Taenia solium cysticercosis vaccine: an epitope shared by Taenia crassiceps and Taenia solium protects mice against experimental cysticercosis.
    Toledo A; Larralde C; Fragoso G; Gevorkian G; Manoutcharian K; Hernández M; Acero G; Rosas G; López-Casillas F; Garfias CK; Vázquez R; Terrazas I; Sciutto E
    Infect Immun; 1999 May; 67(5):2522-30. PubMed ID: 10225916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inexpensive anti-cysticercosis vaccine: S3Pvac expressed in heat inactivated M13 filamentous phage proves effective against naturally acquired Taenia solium porcine cysticercosis.
    Morales J; Martínez JJ; Manoutcharian K; Hernández M; Fleury A; Gevorkian G; Acero G; Blancas A; Toledo A; Cervantes J; Maza V; Quet F; Bonnabau H; de Aluja AS; Fragoso G; Larralde C; Sciutto E
    Vaccine; 2008 Jun; 26(23):2899-905. PubMed ID: 18440675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic capacity of the synthetic peptide-based vaccine against Taenia solium cysticercosis in pigs.
    de Aluja AS; Villalobos NM; Nava G; Toledo A; Martínez JJ; Plancarte A; Rodarte LF; Fragoso G; Sciutto E
    Vaccine; 2005 Jul; 23(31):4062-9. PubMed ID: 15927324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of protection against porcine cysticercosis by vaccination with recombinant oncosphere antigens.
    Flisser A; Gauci CG; Zoli A; Martinez-Ocaña J; Garza-Rodriguez A; Dominguez-Alpizar JL; Maravilla P; Rodriguez-Canul R; Avila G; Aguilar-Vega L; Kyngdon C; Geerts S; Lightowlers MW
    Infect Immun; 2004 Sep; 72(9):5292-7. PubMed ID: 15322025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant bacteriophage-based multiepitope vaccine against Taenia solium pig cysticercosis.
    Manoutcharian K; Díaz-Orea A; Gevorkian G; Fragoso G; Acero G; González E; De Aluja A; Villalobos N; Gómez-Conde E; Sciutto E
    Vet Immunol Immunopathol; 2004 May; 99(1-2):11-24. PubMed ID: 15113650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective protection induced by three different versions of the porcine S3Pvac anticysticercosis vaccine against rabbit experimental Taenia pisiformis cysticercosis.
    Betancourt MA; de Aluja AS; Sciutto E; Hernández M; Bobes RJ; Rosas G; Hernández B; Fragoso G; Hallal-Calleros C; Aguilar L; Flores-Peréz I
    Vaccine; 2012 Apr; 30(17):2760-7. PubMed ID: 22349522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective immunity against Taenia crassiceps murine cysticercosis induced by DNA vaccination with a Taenia saginata tegument antigen.
    Rosas G; Fragoso G; Garate T; Hernández B; Ferrero P; Foster-Cuevas M; Parkhouse RM; Harrison LJ; Briones SL; González LM; Sciutto E
    Microbes Infect; 2002 Nov; 4(14):1417-26. PubMed ID: 12475632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA vaccine against Taenia solium cysticercosis expressed as a modified hepatitis B virus core particle containing three epitopes shared by Taenia crassiceps and Taenia solium.
    Wu L; Diao Z; Deng X; Gao J; Zhou Z; Liu Y; Wang Y
    J Nanosci Nanotechnol; 2005 Aug; 5(8):1204-10. PubMed ID: 16193978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of protection against porcine cysticercosis in growing pigs by DNA vaccination.
    Guo A; Jin Z; Zheng Y; Hai G; Yuan G; Li H; Cai X
    Vaccine; 2007 Jan; 25(1):170-5. PubMed ID: 16750874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of S3Pvac anti-cysticercosis vaccine components: implications for the development of an anti-cestodiasis vaccine.
    Rassy D; Bobes RJ; Rosas G; Anaya VH; Brehm K; Hernández B; Cervantes J; Pedraza S; Morales J; Villalobos N; de Aluja AS; Laclette JP; Nunes CM; Biondi GF; Fragoso G; Hernández M; Sciutto E
    PLoS One; 2010 Jun; 5(6):e11287. PubMed ID: 20585656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Toward development of a Taenia solium paramyosin-based vaccine against porcine cysticercosis].
    Solís CF; Vázquez-Talavera J; Laclette JP
    Gac Med Mex; 2004; 140(2):129-38. PubMed ID: 15162945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards the development of an oral vaccine against porcine cysticercosis: expression of the protective HP6/TSOL18 antigen in transgenic carrots cells.
    Monreal-Escalante E; Govea-Alonso DO; Hernández M; Cervantes J; Salazar-González JA; Romero-Maldonado A; Rosas G; Garate T; Fragoso G; Sciutto E; Rosales-Mendoza S
    Planta; 2016 Mar; 243(3):675-85. PubMed ID: 26613600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taenia crassiceps as a model for Taenia solium and the S3Pvac vaccine.
    Sciutto E; Fragoso G; Larralde C
    Parasite Immunol; 2011 Jan; 33(1):79-80. PubMed ID: 21155844
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.